![Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma](https://oncodaily.com/pub/uploads/2024/07/photo-2-1280x960.jpg)
Jul 3, 2024, 02:35
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X:
“Absolutely abscopal responses …. in myeloma??
Fascinating small Ph2 trial in The Lancet Haematology by Khan Sagar Lonial et al:
Pembro q3wk + 1 Fx RT to EMD sites… 7/25 responders, inc. 2 CRs. Better than I might’ve guessed for pembro monoTx in multiple myeloma.”
Read further.
Source: Rahul Banerjee/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 1, 2024, 17:00